PSI reduces trial identification with AI

PSI CRO has significantly reduced the time required for clinical trial site identification, cutting it from weeks to mere minutes. This acceleration is achieved through the use of an AI agent powered by Arango's Contextual Data Platform. The innovative application of AI streamlines a critical and time-consuming aspect of clinical research. This advancement promises to speed up the drug development process and bring new therapies to market more efficiently.